Lyell Immunopharma Inc. (LYEL)
NASDAQ: LYEL
· Real-Time Price · USD
10.07
0.33 (3.39%)
At close: Jun 16, 2025, 3:59 PM
Lyell Immunopharma Revenue
Lyell Immunopharma reported an annual revenue of $61K, reflecting a -53.08% growth. For the quarter ending March 31, 2025, Lyell Immunopharma generated $7K in revenue.
Revenue (ttm)
$61K
Revenue Growth
-53.08%
Price / Sales Ratio
2743.4
Revenue / Employee
$203.33
Employees
300
Market Cap
149.19M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|